I spoke with Dawson James rep yesterday. Same guy working the NGIO deal was part of another IPO which priced at $9 but ran to $40. Needless to say he is looking forward to what happens with NGIO given the $500 million plus valuation.
(6)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
